MA27065A1 - Composes inhibant la liberation des cytokines inflammatoires. - Google Patents

Composes inhibant la liberation des cytokines inflammatoires.

Info

Publication number: MA27065A1
Authority: MA; Morocco
Prior art keywords: substituted; inflammatory cytokines; release; unsubstituted; amines
Prior art date: 2001-09-20

Application number

MA27568A

Other languages

English (en)

Inventor

Michael Phillip Clark

Jane Far-Jine Djung

Matthew John Laufersweiler

Biswanath De

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-20

Filing date

2004-03-10

Publication date

2004-12-20

2004-03-10 Application filed by Procter & Gamble filed Critical Procter & Gamble

2004-12-20 Publication of MA27065A1 publication Critical patent/MA27065A1/fr

Links

150000001875 compounds Chemical class 0.000 title abstract 3
102000004127 Cytokines Human genes 0.000 title abstract 2
108090000695 Cytokines Proteins 0.000 title abstract 2
230000002757 inflammatory effect Effects 0.000 title abstract 2
230000002401 inhibitory effect Effects 0.000 title 1
150000001412 amines Chemical class 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
125000001072 heteroaryl group Chemical group 0.000 abstract 2
150000001408 amides Chemical class 0.000 abstract 1
125000002619 bicyclic group Chemical group 0.000 abstract 1
125000002618 bicyclic heterocycle group Chemical group 0.000 abstract 1
125000002837 carbocyclic group Chemical group 0.000 abstract 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
150000007942 carboxylates Chemical class 0.000 abstract 1
150000002170 ethers Chemical class 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical class O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/20—Spiro-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Communicable Diseases (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Oncology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

MA27568A 2001-09-20 2004-03-10 Composes inhibant la liberation des cytokines inflammatoires. MA27065A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US32362501P	2001-09-20	2001-09-20

Publications (1)

Publication Number	Publication Date
MA27065A1 true MA27065A1 (fr)	2004-12-20

Family

ID=23259997

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
MA27567A MA27064A1 (fr)	2001-09-20	2004-03-10	6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones spirocycliques regulant les cytokines inflammatoires.
MA27568A MA27065A1 (fr)	2001-09-20	2004-03-10	Composes inhibant la liberation des cytokines inflammatoires.
MA27569A MA27066A1 (fr)	2001-09-20	2004-03-10	6,7-DIHYDRO-5H-PYRAZOLO[1,2-A]PYRAZOL-1-ONES CONTRôLANT LES CYTOKINES INFLAMMATOIRES.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
MA27567A MA27064A1 (fr)	2001-09-20	2004-03-10	6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones spirocycliques regulant les cytokines inflammatoires.

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
MA27569A MA27066A1 (fr)	2001-09-20	2004-03-10	6,7-DIHYDRO-5H-PYRAZOLO[1,2-A]PYRAZOL-1-ONES CONTRôLANT LES CYTOKINES INFLAMMATOIRES.

Country Status (32)

Country	Link
US (2)	US6821971B2 (fr)
EP (3)	EP1427728B1 (fr)
JP (3)	JP2005504082A (fr)
KR (4)	KR20040035837A (fr)
CN (3)	CN1257905C (fr)
AR (3)	AR037502A1 (fr)
AT (3)	ATE356126T1 (fr)
AU (2)	AU2002327690B2 (fr)
BR (3)	BR0212673A (fr)
CA (3)	CA2461071A1 (fr)
CO (3)	CO5560590A2 (fr)
CY (1)	CY1106398T1 (fr)
CZ (3)	CZ2004345A3 (fr)
DE (3)	DE60202782T2 (fr)
DK (2)	DK1427732T3 (fr)
EG (2)	EG24363A (fr)
ES (3)	ES2282459T3 (fr)
HU (3)	HUP0402500A3 (fr)
IL (3)	IL160682A0 (fr)
MA (3)	MA27064A1 (fr)
MX (3)	MXPA04002574A (fr)
MY (2)	MY129329A (fr)
NO (2)	NO20041594L (fr)
NZ (3)	NZ531063A (fr)
PE (3)	PE20030446A1 (fr)
PL (3)	PL370415A1 (fr)
PT (3)	PT1427728E (fr)
RU (3)	RU2278864C2 (fr)
SA (1)	SA03230529B1 (fr)
SK (3)	SK1492004A3 (fr)
WO (3)	WO2003024971A1 (fr)
ZA (3)	ZA200401260B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7087615B2 (en)	2001-09-20	2006-08-08	The Procter & Gamble Company	6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia
US6849627B2 (en)	2001-09-20	2005-02-01	The Procter & Gamble Company	6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6730668B2 (en) *	2001-09-20	2004-05-04	The Procter & Gamble Company	6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7473695B2 (en) *	2001-10-22	2009-01-06	Mitsubishi Tanabe Pharma Corporation	4-imidazolin-2-one compounds
US6677337B2 (en) *	2002-03-19	2004-01-13	The Procter & Gamble Company	1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
JP2006501263A (ja) *	2002-09-09	2006-01-12	アムジエン・インコーポレーテツド	炎症治療用のＴＮＦ−αおよびインターロイキン低下剤としての１，４，５−置換１，２−ジヒドロ−ピラゾール−３−オンおよび３−アルコキシ−１Ｈ−ピラゾール誘導体
WO2004087696A1 (fr) *	2003-04-03	2004-10-14	Merck Patent Gmbh	Derives de l'acide pyrazolidine-1,2-dicarboxylique-1-(phenylamide)-2-(phenylamide) comme inhibiteurs du facteur de coagulation xa dans le traitement de thromboses
GB0308466D0 (en) *	2003-04-11	2003-05-21	Novartis Ag	Organic compounds
US7482356B2 (en) *	2003-11-10	2009-01-27	The Procter & Gamble Company	Bicyclic pyrazolone cytokine inhibitors
AU2007238071B2 (en) *	2006-04-18	2012-06-07	Abbvie Inc.	Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
DE102008060549A1 (de)	2008-12-04	2010-06-10	MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.	Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
PE20120325A1 (es) *	2009-05-19	2012-04-12	Dow Agrosciences Llc	Aminopirimidinas sustituidas con arilo como agentes fungicidas
WO2016205284A1 (fr)	2015-06-15	2016-12-22	Cummins Inc.	Dispositif d'élasticité pour chambre de combustion
US20190060286A1 (en)	2016-02-29	2019-02-28	University Of Florida Research Foundation, Incorpo	Chemotherapeutic Methods
CN107033090B (zh) *	2017-05-16	2019-05-07	无锡捷化医药科技有限公司	一种1,2,3,4-四氢噌啉的制备方法
RU2721684C1 (ru) *	2019-09-06	2020-05-21	Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет"	Метил 2,3,8-триоксо-4-фенилтетрагидро-6Н-пиразоло[1,2-а]пирроло[2,3-c]пиразол-9а(1Н)-карбоксилаты
US20240425524A1 (en) *	2021-10-27	2024-12-26	Merck Sharp & Dohme Llc	Spirotricycle ripk1 inhibitors and methods of uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1054291A (fr) *	1963-02-26
GB1124982A (en) *	1965-02-09	1968-08-21	Lepetit Spa	Diazabicyclo octanes and derivatives thereof
CH529153A (fr)	1969-10-27	1972-10-15	Lepetit Spa	Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US5358924A (en) *	1991-03-21	1994-10-25	Bayer Aktiengesellschaft	3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
DK0640086T3 (da) *	1992-05-15	1999-12-06	Merrell Pharma Inc	Mercaptoacetylamido-pyridazo[1,2-a][1,2]diazepin-derivateranvendelige som enkephalinase- og ACE-inhibitorer
GB9303993D0 (en) *	1993-02-26	1993-04-14	Fujisawa Pharmaceutical Co	New heterocyclic derivatives
CN1272324C (zh) *	1999-09-07	2006-08-30	辛根塔参与股份公司	新颖的除草剂
US6730668B2 (en) *	2001-09-20	2004-05-04	The Procter & Gamble Company	6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

2002
- 2002-09-18 US US10/245,927 patent/US6821971B2/en not_active Expired - Fee Related
- 2002-09-18 US US10/246,499 patent/US6566357B1/en not_active Expired - Fee Related
- 2002-09-20 HU HU0402500A patent/HUP0402500A3/hu unknown
- 2002-09-20 CA CA002461071A patent/CA2461071A1/fr not_active Abandoned
- 2002-09-20 WO PCT/US2002/030135 patent/WO2003024971A1/fr not_active Ceased
- 2002-09-20 BR BR0212673-7A patent/BR0212673A/pt not_active IP Right Cessation
- 2002-09-20 SK SK149-2004A patent/SK1492004A3/sk unknown
- 2002-09-20 MX MXPA04002574A patent/MXPA04002574A/es active IP Right Grant
- 2002-09-20 RU RU2004111805/04A patent/RU2278864C2/ru active
- 2002-09-20 SK SK150-2004A patent/SK1502004A3/sk unknown
- 2002-09-20 KR KR10-2004-7004046A patent/KR20040035837A/ko not_active Ceased
- 2002-09-20 MY MYPI20023518A patent/MY129329A/en unknown
- 2002-09-20 PE PE2002000924A patent/PE20030446A1/es not_active Application Discontinuation
- 2002-09-20 WO PCT/US2002/030134 patent/WO2003024970A1/fr not_active Ceased
- 2002-09-20 DK DK02799017T patent/DK1427732T3/da active
- 2002-09-20 NZ NZ531063A patent/NZ531063A/en not_active IP Right Cessation
- 2002-09-20 AR ARP020103549A patent/AR037502A1/es not_active Application Discontinuation
- 2002-09-20 CZ CZ2004345A patent/CZ2004345A3/cs unknown
- 2002-09-20 BR BR0212716-4A patent/BR0212716A/pt not_active IP Right Cessation
- 2002-09-20 CN CNB028182286A patent/CN1257905C/zh not_active Expired - Fee Related
- 2002-09-20 PL PL02370415A patent/PL370415A1/xx not_active Application Discontinuation
- 2002-09-20 ES ES02763693T patent/ES2282459T3/es not_active Expired - Lifetime
- 2002-09-20 PT PT02763693T patent/PT1427728E/pt unknown
- 2002-09-20 ES ES02799017T patent/ES2268154T3/es not_active Expired - Lifetime
- 2002-09-20 JP JP2003528818A patent/JP2005504082A/ja active Pending
- 2002-09-20 SK SK148-2004A patent/SK1482004A3/sk unknown
- 2002-09-20 ES ES02763692T patent/ES2237691T3/es not_active Expired - Lifetime
- 2002-09-20 DE DE60202782T patent/DE60202782T2/de not_active Expired - Lifetime
- 2002-09-20 IL IL16068202A patent/IL160682A0/xx unknown
- 2002-09-20 WO PCT/US2002/030133 patent/WO2003024973A1/fr not_active Ceased
- 2002-09-20 EP EP02763693A patent/EP1427728B1/fr not_active Expired - Lifetime
- 2002-09-20 KR KR1020047004043A patent/KR100656126B1/ko not_active Expired - Fee Related
- 2002-09-20 MY MYPI20023502A patent/MY129069A/en unknown
- 2002-09-20 AU AU2002327690A patent/AU2002327690B2/en not_active Ceased
- 2002-09-20 KR KR1020047004045A patent/KR100623879B1/ko not_active Expired - Fee Related
- 2002-09-20 KR KR1020067006983A patent/KR20060036125A/ko not_active Ceased
- 2002-09-20 HU HU0402378A patent/HUP0402378A3/hu unknown
- 2002-09-20 DE DE60218704T patent/DE60218704T2/de not_active Expired - Lifetime
- 2002-09-20 PE PE2002000925A patent/PE20030474A1/es not_active Application Discontinuation
- 2002-09-20 MX MXPA04002570A patent/MXPA04002570A/es active IP Right Grant
- 2002-09-20 JP JP2003528820A patent/JP2005504083A/ja active Pending
- 2002-09-20 AT AT02763693T patent/ATE356126T1/de not_active IP Right Cessation
- 2002-09-20 PE PE2002000923A patent/PE20030430A1/es not_active Application Discontinuation
- 2002-09-20 PT PT02799017T patent/PT1427732E/pt unknown
- 2002-09-20 DE DE60213108T patent/DE60213108T2/de not_active Expired - Fee Related
- 2002-09-20 PL PL02370351A patent/PL370351A1/xx not_active Application Discontinuation
- 2002-09-20 AR ARP020103548A patent/AR037145A1/es unknown
- 2002-09-20 JP JP2003528817A patent/JP2005504081A/ja active Pending
- 2002-09-20 CN CNB028183800A patent/CN1249066C/zh not_active Expired - Fee Related
- 2002-09-20 AT AT02799017T patent/ATE332901T1/de not_active IP Right Cessation
- 2002-09-20 AU AU2002334641A patent/AU2002334641B2/en not_active Expired - Fee Related
- 2002-09-20 PT PT02763692T patent/PT1427727E/pt unknown
- 2002-09-20 BR BR0212905-1A patent/BR0212905A/pt not_active IP Right Cessation
- 2002-09-20 CN CNB028182294A patent/CN1250551C/zh not_active Expired - Fee Related
- 2002-09-20 PL PL02370362A patent/PL370362A1/xx not_active Application Discontinuation
- 2002-09-20 CZ CZ2004358A patent/CZ2004358A3/cs unknown
- 2002-09-20 MX MXPA04002569A patent/MXPA04002569A/es active IP Right Grant
- 2002-09-20 CA CA002461073A patent/CA2461073A1/fr not_active Abandoned
- 2002-09-20 NZ NZ531122A patent/NZ531122A/en unknown
- 2002-09-20 DK DK02763693T patent/DK1427728T3/da active
- 2002-09-20 AR ARP020103550A patent/AR037237A1/es not_active Application Discontinuation
- 2002-09-20 NZ NZ531123A patent/NZ531123A/en not_active IP Right Cessation
- 2002-09-20 EP EP02799017A patent/EP1427732B1/fr not_active Expired - Lifetime
- 2002-09-20 IL IL16074102A patent/IL160741A0/xx unknown
- 2002-09-20 EP EP02763692A patent/EP1427727B1/fr not_active Expired - Lifetime
- 2002-09-20 IL IL16074202A patent/IL160742A0/xx unknown
- 2002-09-20 HU HU0500752A patent/HUP0500752A2/hu unknown
- 2002-09-20 RU RU2004111806/04A patent/RU2272040C2/ru not_active IP Right Cessation
- 2002-09-20 AT AT02763692T patent/ATE287887T1/de not_active IP Right Cessation
- 2002-09-20 CZ CZ2004361A patent/CZ2004361A3/cs unknown
- 2002-09-20 RU RU2004111803/04A patent/RU2299885C2/ru active
- 2002-09-20 CA CA002461072A patent/CA2461072A1/fr not_active Abandoned
- 2002-09-21 EG EG2002091037A patent/EG24363A/xx active
- 2002-09-21 EG EG2002091039A patent/EG24413A/xx active
2003
- 2003-01-26 SA SA3230529A patent/SA03230529B1/ar unknown
2004
- 2004-02-17 ZA ZA200401260A patent/ZA200401260B/en unknown
- 2004-02-20 ZA ZA200401403A patent/ZA200401403B/en unknown
- 2004-02-20 ZA ZA200401402A patent/ZA200401402B/en unknown
- 2004-03-09 CO CO04021425A patent/CO5560590A2/es not_active Application Discontinuation
- 2004-03-09 CO CO04021424A patent/CO5560589A2/es not_active Application Discontinuation
- 2004-03-10 MA MA27567A patent/MA27064A1/fr unknown
- 2004-03-10 MA MA27568A patent/MA27065A1/fr unknown
- 2004-03-10 MA MA27569A patent/MA27066A1/fr unknown
- 2004-03-12 CO CO04023010A patent/CO5560579A2/es not_active Application Discontinuation
- 2004-04-19 NO NO20041594A patent/NO20041594L/no not_active Application Discontinuation
- 2004-04-20 NO NO20041605A patent/NO20041605L/no not_active Application Discontinuation
2007
- 2007-03-20 CY CY20071100383T patent/CY1106398T1/el unknown

Also Published As

Publication number	Publication date
PE20030446A1 (es)	2003-07-21
AR037237A1 (es)	2004-11-03
DE60202782D1 (de)	2005-03-03
NZ531123A (en)	2006-08-31
DE60213108D1 (de)	2006-08-24
DE60218704D1 (de)	2007-04-19
CZ2004345A3 (cs)	2004-06-16
PT1427728E (pt)	2007-05-31
HUP0402500A2 (hu)	2005-03-29
RU2004111806A (ru)	2005-03-27
MY129069A (en)	2007-03-30
MXPA04002569A (es)	2004-05-31
CO5560589A2 (es)	2005-09-30
RU2004111805A (ru)	2005-04-10
US20030105084A1 (en)	2003-06-05
CN1555375A (zh)	2004-12-15
ZA200401402B (en)	2004-08-27
CZ2004361A3 (cs)	2004-07-14
BR0212905A (pt)	2004-10-13
SK1482004A3 (en)	2004-08-03
EP1427732B1 (fr)	2006-07-12
US6566357B1 (en)	2003-05-20
PE20030474A1 (es)	2003-07-22
DK1427732T3 (da)	2006-10-30
CN1249066C (zh)	2006-04-05
ES2237691T3 (es)	2005-08-01
MXPA04002574A (es)	2004-06-18
EP1427728B1 (fr)	2007-03-07
ATE287887T1 (de)	2005-02-15
US6821971B2 (en)	2004-11-23
HK1071366A1 (en)	2005-07-15
HUP0402500A3 (en)	2008-10-28
NZ531122A (en)	2005-09-30
EP1427732A1 (fr)	2004-06-16
PT1427727E (pt)	2005-06-30
CY1106398T1 (el)	2011-10-12
PL370351A1 (en)	2005-05-16
AR037502A1 (es)	2004-11-17
CO5560590A2 (es)	2005-09-30
SK1502004A3 (en)	2004-09-08
RU2272040C2 (ru)	2006-03-20
CA2461073A1 (fr)	2003-03-27
EG24413A (en)	2009-05-25
PL370362A1 (en)	2005-05-16
WO2003024971A1 (fr)	2003-03-27
SA03230529B1 (ar)	2008-06-21
RU2278864C2 (ru)	2006-06-27
KR100656126B1 (ko)	2006-12-12
RU2299885C2 (ru)	2007-05-27
DE60213108T2 (de)	2007-02-08
ZA200401260B (en)	2004-08-30
MXPA04002570A (es)	2004-05-31
HUP0402378A2 (hu)	2005-02-28
AU2002334641B2 (en)	2007-03-29
BR0212673A (pt)	2004-08-24
IL160682A0 (en)	2004-08-31
HUP0402378A3 (en)	2008-10-28
NO20041605L (no)	2004-06-21
CO5560579A2 (es)	2005-09-30
NZ531063A (en)	2007-08-31
JP2005504083A (ja)	2005-02-10
SK1492004A3 (en)	2004-11-03
ES2282459T3 (es)	2007-10-16
RU2004111803A (ru)	2005-10-10
CA2461071A1 (fr)	2003-03-27
KR20040035836A (ko)	2004-04-29
ZA200401403B (en)	2004-08-30
KR20040035835A (ko)	2004-04-29
DE60202782T2 (de)	2006-01-19
ES2268154T3 (es)	2007-03-16
DE60218704T2 (de)	2007-11-08
BR0212716A (pt)	2004-08-03
CN1250551C (zh)	2006-04-12
PE20030430A1 (es)	2003-06-24
IL160741A0 (en)	2004-08-31
JP2005504082A (ja)	2005-02-10
KR20060036125A (ko)	2006-04-27
NO20041594L (no)	2004-06-21
EG24363A (en)	2009-03-04
MA27064A1 (fr)	2004-12-20
DK1427728T3 (da)	2007-07-09
WO2003024973A1 (fr)	2003-03-27
CN1257905C (zh)	2006-05-31
KR20040035837A (ko)	2004-04-29
AR037145A1 (es)	2004-10-27
CN1556811A (zh)	2004-12-22
JP2005504081A (ja)	2005-02-10
PL370415A1 (en)	2005-05-30
CZ2004358A3 (cs)	2004-07-14
KR100623879B1 (ko)	2006-09-19
EP1427727A1 (fr)	2004-06-16
CA2461072A1 (fr)	2003-03-27
CN1555379A (zh)	2004-12-15
EP1427727B1 (fr)	2005-01-26
IL160742A0 (en)	2004-08-31
WO2003024970A1 (fr)	2003-03-27
MY129329A (en)	2007-03-30
ATE356126T1 (de)	2007-03-15
AU2002327690B2 (en)	2006-07-20
EP1427728A1 (fr)	2004-06-16
MA27066A1 (fr)	2004-12-20
HUP0500752A2 (en)	2006-01-30
HK1071565A1 (en)	2005-07-22
ATE332901T1 (de)	2006-08-15
PT1427732E (pt)	2006-12-29

Publication	Publication Date	Title
PL370415A1 (en)	2005-05-30	Compounds which inhibit the release of inflammatory cytokines
EP1460067A4 (fr)	2005-12-07	Derive bicyclique, procede de production de ce derive et utilisation correspondante
WO2006109075A3 (fr)	2006-11-30	Composes pharmaceutiques
GB0005357D0 (en)	2000-04-26	Compounds
EP1724262A4 (fr)	2009-10-21	Derive de 1-(2h)-isoquinolone
WO2002089800A3 (fr)	2004-05-06	Derives d'amines cycliques n-aroyl utilises comme antagonistes du recepteur d'orexine
NO20042584L (no)	2004-06-18	Dibenzylaminforbindelser og farmasoytisk anvendelse derav
MXPA03010129A (es)	2004-03-10	N-aroilaminas-ciclicas.
TW200607504A (en)	2006-03-01	Cinnamide compound
EP1364950A4 (fr)	2005-03-09	Derive de pyridopyrimidine ou naphthyridine
MY143245A (en)	2011-04-15	4- 2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
MY161992A (en)	2017-05-31	Novel tetrahydroisoquinoline derivative
NO20023298D0 (no)	2002-07-08	Nye imidazolderivater
NO20063111L (no)	2006-09-05	Fremgangsmate for fremstilling av tiazolpyrimidiner
MY139258A (en)	2009-09-30	Carbamoyl-type benzofuran derivatives
EA200401099A1 (ru)	2005-02-24	Производные гетероциклического амида
TR200401488T4 (tr)	2004-08-23	CNS bozukluklarının tedavisinde faydalı indol türevleri
IS7911A (is)	2005-06-23	Ímídasólafleiður með sækni í alfa 2 viðtakavirkni
NO20041601L (no)	2004-06-21	Forbindelse som hemmer frigjøringen av inflammatoriske cytokiner
DE60009932D1 (de)	2004-05-19	5-aminoalkyl- und 5-aminocarbonylsubstituierte indole
ATE262522T1 (de)	2004-04-15	Benzimidazolverbindungen
NO20062187L (no)	2006-07-07	Furanderivat som EP4-reseptorantagonister
DE602004017878D1 (de)	2009-01-02	8-chlor-2,3-benzodiazepinderivate